TORONTO, April 09, 2018 (GLOBE NEWSWIRE) — Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) today announced the appointment of Paul Hart as Chief Financial Officer of the Company.

The Company is pleased to welcome Mr. Hart as its CFO, a seasoned Chief Financial Officer with over twenty-five years of leadership experience with public companies (TSX, TSX-V, NASDAQ), spanning the clean technology, genomics, software, internet, venture capital and financial services industries. He has been responsible for strategic planning, corporate governance, finance and operations, mergers and acquisitions, investor relations and fund-raising in capital markets in North America and Europe. He has been a director on both public and private company Boards, as well as heading both Audit and Disclosure Committees. Paul holds BA (Honors) and MBA (Finance) degrees. Mr. Hart is also a CA, a CPA and Chartered Director.

“We are delighted to welcome Paul to the senior management team,” said Larry Bortles, Chairman and CEO. “His knowledge and previous experience with rapidly growing companies is expected to be extremely beneficial as we continue to build market share in all three of our operating divisions – our MFT medical cannabis, cannabinoid therapy education clinics, our Knalysis medical cannabis data collection and analysis technology team, and our Abba Medix cannabis grow operations,” continued Mr. Bortles. “We expect this to be an exciting and rewarding time over the coming months, and Paul’s leadership will be essential not only in finance and operations, but also in our strategic, investor relations and fund-raising activities,” concluded Mr. Bortles.

“We would also like to thank Mike Johnston for his past contributions and look forward to his assistance during the transition. Mike has been important to the Company over the past few years and we acknowledge his support during the difficult periods in the Company’s history,” adds Mr. Bortles.

Mr. Hart’s appointment as Chief Financial Officer of the Company is effective immediately and is subject to review and approval by the Canada Securities Exchange.

Canada House Wellness Group Inc.
Canada House is the parent company of Marijuana for Trauma Inc., Knalysis Technologies and Abba Medix Corp. The Company’s goal is to become a marketplace leader through strategic partnerships, mergers, and acquisitions to create a fully integrated cannabis therapy company. For more information please visit or

For further information, please contact:
Boom Capital Markets
Steve Low

Canada House Wellness Group, Inc.
Larry Bortles

Cautionary Statement Regarding Forward‐Looking Information. Certain statements within this news release pertaining to the Company constitute “forward‐looking statements”, within the meaning of applicable securities laws, including without limitation, statements regarding future estimates, business plans and/or objectives, sales programs, forecasts and projections, assumptions, expectations, and/or beliefs of future performance, are “forward‐looking statements”. Such “forward‐looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements. Forward‐looking statements include, but are not limited to, statements with respect to the anticipated effects of the financing, regulatory changes, timeliness of government approvals for the granting of permits and licenses, changes in medical marijuana prices, actual operating performance of facilities, competition and other risks affecting the Company in particular and the medical marijuana industry generally, including those set out in the Company’s public disclosure record. The Company assumes no responsibility to update or revise forward‐looking information to reflect new events or circumstances unless required by law.

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.